All lobbying filings

W STRATEGIES, LLC

Lobbying for ASTRAZENECA PHARMACEUTICALS LP · Biopharmaceutical Company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Delaware · House · Senate · $80,000.00 income · posted Apr 18, 2025

Official filing document

Bills named in this filing 2

HR 5376
Impacts and Outcomes for Health Career Training Act
HR 946
ORPHAN Cures Act

Lobbying activity 2

Medicare/Medicaid

Implementation of H.R.5376 - Inflation Reduction Act of 2022 and potential reforms involving the treatment of orphan drugs. H.R.946 - ORPHAN Cures Act.

Health Issues

Issues related to insurance coverage of specialty treatments.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.